# Liraglutide

NDC: 0480-7250
Generic name: Liraglutide
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250828
Marketing ended: 20270930
FDA application: ANDA214568

## Active ingredients

- LIRAGLUTIDE: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-7250"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-7250
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=625ac780-70a9-41e4-a892-bcba0f803f1c